Polar Capital’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-6,881
Closed -$671K 320
2015
Q1
$671K Sell
6,881
-3,403
-33% -$332K 0.01% 260
2014
Q4
$954K Buy
+10,284
New +$954K 0.02% 240